4Lenzen R, Borchard F, Lubke H, et al. Colitis ulcerosa complicated by malignant lymphoma: case report and analysis of published works. Gut, 1995,36:306-310.
5Kopdcova M, Rejchrt S. Tycova V, et al. Tumorous neo- vaseularization: a newly recognized endoscopic feature of intestinal non- Hodgkin lymphoma. Endoscopy. 2007.39 Suppl 1: E95.
6Garcia-Sanchez MV, Poyato-Gonzalez A, Giraldez-Jimenez MD, et al. MALT lymphoma in a patient with Crohn's disease. A causal or incidental association? Gastroenterol Hepatol, 2006,29 : 74-76.
7Bernstein CN, Blanchard JF, Kliewer E, et al. Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer, 2001,91 : 854-862.
8Van Domselaar M, Lopez San Roman A. Bastos Oreiro M,et al. Lymphoproliferative disorders in an inflammatory bowel disease unit. Gastroenterol Hepatol, 2010,33 : 12-16.
9Kandiel A, Fraser AG, Knrelitz BI, et al. Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6 mereaptopurine. Gut, 2005, 54: 1121-1125.
10Beaugerie L, Brousse N, Bouvier AM, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: a prospective observational cohort study. Lancet. 2009.374: 1617-1625.
